{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:33:37Z","timestamp":1777865617758,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82103629"],"award-info":[{"award-number":["82103629"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Key Scientific and Technological Project of Henan Province","award":["242102310208"],"award-info":[{"award-number":["242102310208"]}]},{"name":"The Project of Basic Research Fund of Henan Institute of Medical and Pharmacological Sciences","award":["2023BP0202"],"award-info":[{"award-number":["2023BP0202"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02248-1","type":"journal-article","created":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T12:24:45Z","timestamp":1774182285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CXCL12\/ZNF503\/GATA3\/MMP1 axis promotes tumor progression and metastasis of triple-negative breast cancer"],"prefix":"10.1186","volume":"28","author":[{"given":"Siyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aichen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lulu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiqi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,22]]},"reference":[{"key":"2248_CR1","doi-asserted-by":"publisher","first-page":"106535","DOI":"10.1016\/j.intimp.2020.106535","volume":"84","author":"K Barzaman","year":"2020","unstructured":"Barzaman K, Karami J, Zarei Z, Hosseinzadeh A, Kazemi MH, Moradi-Kalbolandi S, et al. Breast cancer: Biology, biomarkers, and treatments. Int Immunopharmacol. 2020;84:106535.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2248_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"35","key":"2248_CR3","doi-asserted-by":"publisher","first-page":"e4614","DOI":"10.1097\/MD.0000000000004614","volume":"95","author":"ML Plasilova","year":"2016","unstructured":"Plasilova ML, Hayse B, Killelea BK, Horowitz NR, Chagpar AB, Lannin DR. Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database. Med (Baltim). 2016;95(35):e4614.","journal-title":"Med (Baltim)"},{"issue":"3","key":"2248_CR4","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2248_CR5","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s10549-021-06342-0","volume":"189","author":"S Reid","year":"2021","unstructured":"Reid S, Haddad D, Tezak A, Weidner A, Wang X, Mautz B, et al. Impact of molecular subtype and race on HR+, HER2- breast cancer survival. Breast Cancer Res Treat. 2021;189(3):845\u201352.","journal-title":"Breast Cancer Res Treat"},{"issue":"16","key":"2248_CR6","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","volume":"28","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28(16):2784\u201395.","journal-title":"J Clin Oncol"},{"issue":"31","key":"2248_CR7","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31(31):3997\u20134013.","journal-title":"J Clin Oncol"},{"issue":"4","key":"2248_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000331643","volume":"6","author":"Z Elsawaf","year":"2011","unstructured":"Elsawaf Z, Sinn HP. Triple-Negative Breast Cancer: Clinical and Histological Correlations. Breast Care (Basel). 2011;6(4):273\u20138.","journal-title":"Breast Care (Basel)"},{"issue":"15 Pt 1","key":"2248_CR9","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13(15 Pt 1):4429\u201334.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2248_CR10","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.7314\/APJCP.2016.17.4.1595","volume":"17","author":"FZ Mouh","year":"2016","unstructured":"Mouh FZ, Mzibri ME, Slaoui M, Amrani M. Recent Progress in Triple Negative Breast Cancer Research. Asian Pac J Cancer Prev. 2016;17(4):1595\u2013608.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"2248_CR11","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/jcb.20255","volume":"93","author":"M Nakamura","year":"2004","unstructured":"Nakamura M, Runko AP, Sagerstrom CG. A novel subfamily of zinc finger genes involved in embryonic development. J Cell Biochem. 2004;93(5):887\u201395.","journal-title":"J Cell Biochem"},{"issue":"6","key":"2248_CR12","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1074\/jbc.M114.611202","volume":"290","author":"P Shahi","year":"2015","unstructured":"Shahi P, Slorach EM, Wang CY, Chou J, Lu A, Ruderisch A, et al. The Transcriptional Repressor ZNF503\/Zeppo2 Promotes Mammary Epithelial Cell Proliferation and Enhances Cell Invasion. J Biol Chem. 2015;290(6):3803\u201313.","journal-title":"J Biol Chem"},{"issue":"4","key":"2248_CR13","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1007\/s13577-022-00706-4","volume":"35","author":"AA El-Arabey","year":"2022","unstructured":"El-Arabey AA, Abdalla M. The role of GATA3 in the metastasis of triple-negative breast cancer and high-grade serous ovarian cancer. Hum Cell. 2022;35(4):1298\u2013300.","journal-title":"Hum Cell"},{"issue":"1","key":"2248_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.canlet.2016.03.038","volume":"376","author":"J Liu","year":"2016","unstructured":"Liu J, Prager-van der Smissen WJ, Look MP, Sieuwerts AM, Smid M, Meijer-van Gelder ME, et al. GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease. Cancer Lett. 2016;376(1):104\u20139.","journal-title":"Cancer Lett"},{"issue":"2","key":"2248_CR15","doi-asserted-by":"publisher","first-page":"720","DOI":"10.7150\/thno.65796","volume":"12","author":"F Bai","year":"2022","unstructured":"Bai F, Zheng C, Liu X, Chan HL, Liu S, Ma J, et al. Loss of function of GATA3 induces basal-like mammary tumors. Theranostics. 2022;12(2):720\u201333.","journal-title":"Theranostics"},{"issue":"24","key":"2248_CR16","doi-asserted-by":"publisher","first-page":"11259","DOI":"10.1158\/0008-5472.CAN-05-2495","volume":"65","author":"R Mehra","year":"2005","unstructured":"Mehra R, Varambally S, Ding L, Shen R, Sabel MS, Ghosh D, et al. Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Res. 2005;65(24):11259\u201364.","journal-title":"Cancer Res"},{"issue":"12","key":"2248_CR17","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1073\/pnas.1701690114","volume":"114","author":"P Shahi","year":"2017","unstructured":"Shahi P, Wang CY, Lawson DA, Slorach EM, Lu A, Yu Y, et al. ZNF503\/Zpo2 drives aggressive breast cancer progression by down-regulation of GATA3 expression. Proc Natl Acad Sci U S A. 2017;114(12):3169\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2248_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/1354750X.2023.2201665","volume":"28","author":"S Liu","year":"2023","unstructured":"Liu S, Cao X, Li J, Liu J. ZNF503 combined with GATA3 is a prognostic factor in triple-negative breast cancer. Biomarkers. 2023;28(5):437\u201347.","journal-title":"Biomarkers"},{"issue":"1","key":"2248_CR19","first-page":"46","volume":"3","author":"D Mukherjee","year":"2013","unstructured":"Mukherjee D, Zhao J. The Role of chemokine receptor CXCR4 in breast cancer metastasis. Am J Cancer Res. 2013;3(1):46\u201357.","journal-title":"Am J Cancer Res"},{"issue":"11","key":"2248_CR20","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","volume":"16","author":"BA Teicher","year":"2010","unstructured":"Teicher BA, Fricker SP. CXCL12 (SDF-1)\/CXCR4 pathway in cancer. Clin Cancer Res. 2010;16(11):2927\u201331.","journal-title":"Clin Cancer Res"},{"key":"2248_CR21","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.2147\/OTT.S195661","volume":"12","author":"M Yang","year":"2019","unstructured":"Yang M, Zeng C, Li P, Qian L, Ding B, Huang L, et al. Impact of CXCR4 and CXCR7 knockout by CRISPR\/Cas9 on the function of triple-negative breast cancer cells. Onco Targets Ther. 2019;12:3849\u201358.","journal-title":"Onco Targets Ther"},{"key":"2248_CR22","doi-asserted-by":"crossref","unstructured":"Li Y, Luo H, Lin X, Hua L, Wang J, Xie J, et al. Triterpenes of prunella vulgaris inhibit triple-negative breast cancer by regulating PTP1B\/PI3K\/AKT\/mTOR and IL-24\/CXCL12\/CXCR4 Pathways. Int J Mol Sci. 2025;26(5):1959.","DOI":"10.3390\/ijms26051959"},{"key":"2248_CR23","doi-asserted-by":"crossref","unstructured":"Lee R, Ellison V, Forbes D, Gao C, Katanov D, Kern A, et al. Chemokine CXCL12 Activates CXC receptor 4 metastasis signaling through the upregulation of a CXCL12\/CXCR4\/MDMX (MDM4) Axis. Cancers (Basel). 2024;16(24):4194.","DOI":"10.3390\/cancers16244194"},{"key":"2248_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.biopha.2015.01.020","volume":"71","author":"ZY Song","year":"2015","unstructured":"Song ZY, Gao ZH, Chu JH, Han XZ, Qu XJ. Downregulation of the CXCR4\/CXCL12 axis blocks the activation of the Wnt\/beta-catenin pathway in human colon cancer cells. Biomed Pharmacother. 2015;71:46\u201352.","journal-title":"Biomed Pharmacother"},{"key":"2248_CR25","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.2147\/OTT.S256818","volume":"13","author":"LY Wei","year":"2020","unstructured":"Wei LY, Zhang XJ, Wang L, Hu LN, Zhang XD, Li L, et al. A Six-Epithelial-Mesenchymal Transition Gene Signature May Predict Metastasis of Triple-Negative Breast Cancer. Onco Targets Ther. 2020;13:6497\u2013509.","journal-title":"Onco Targets Ther"},{"key":"2248_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/cancers13225703","volume":"13","author":"Q Lin","year":"2021","unstructured":"Lin Q, Fang X, Liang G, Luo Q, Cen Y, Shi Y, et al. Silencing CTNND1 Mediates Triple-Negative Breast Cancer Bone Metastasis via Upregulating CXCR4\/CXCL12 Axis and Neutrophils Infiltration in Bone. Cancers (Basel). 2021;13:22.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2248_CR27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1139\/bcb-2017-0074","volume":"96","author":"Y Lin","year":"2018","unstructured":"Lin Y, Ma Q, Li L, Wang H. The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-kappaB signaling. Biochem Cell Biol. 2018;96(5):619\u201326.","journal-title":"Biochem Cell Biol"},{"key":"2248_CR28","doi-asserted-by":"crossref","unstructured":"Jiachi M, Xiaowen S, Yimin W, Bangling C, Liyu Q, Yaguo W. Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k\/Akt signaling. Cell Commun Signal CCS. 2019;17(1):119.","DOI":"10.1186\/s12964-019-0432-5"},{"issue":"28","key":"2248_CR29","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.3748\/wjg.v23.i28.5167","volume":"23","author":"JC Ma","year":"2017","unstructured":"Ma JC, Sun XW, Su H, Chen Q, Guo TK, Li Y, et al. Fibroblast-derived CXCL12\/SDF-1alpha promotes CXCL6 secretion and co-operatively enhances metastatic potential through the PI3K\/Akt\/mTOR pathway in colon cancer. World J Gastroenterol. 2017;23(28):5167\u201378.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"2248_CR30","first-page":"12357","volume":"8","author":"S Shan","year":"2015","unstructured":"Shan S, Lv Q, Zhao Y, Liu C, Sun Y, Xi K, et al. Wnt\/beta-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells. Int J Clin Exp Pathol. 2015;8(10):12357\u201367.","journal-title":"Int J Clin Exp Pathol"},{"issue":"7","key":"2248_CR31","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750\u201367.","journal-title":"J Clin Invest"},{"issue":"17","key":"2248_CR32","doi-asserted-by":"publisher","first-page":"8218","DOI":"10.7150\/thno.59280","volume":"11","author":"F Bai","year":"2021","unstructured":"Bai F, Zhang LH, Liu X, Wang C, Zheng C, Sun J, et al. GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer. Theranostics. 2021;11(17):8218\u201333.","journal-title":"Theranostics"},{"issue":"7","key":"2248_CR33","doi-asserted-by":"publisher","first-page":"119768","DOI":"10.1016\/j.bbamcr.2024.119768","volume":"1871","author":"EX Chen","year":"2024","unstructured":"Chen EX, Hu SC, Xu JQ, Liu KY, Tang J, Shen XP, et al. Suppression of GATA3 promotes epithelial-mesenchymal transition and simultaneous cellular senescence in human extravillous trophoblasts. Biochim Biophys Acta Mol Cell Res. 2024;1871(7):119768.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"5","key":"2248_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12032-025-02705-5","volume":"42","author":"AQ Khaleel","year":"2025","unstructured":"Khaleel AQ, Altalbawy FMA, Jabir MS, Jain TFH, Abbot V. CXCR4\/CXCL12 blockade therapy; a new horizon in TNBC therapy. Med Oncol. 2025;42(5):161.","journal-title":"Med Oncol"},{"key":"2248_CR35","doi-asserted-by":"publisher","first-page":"116335","DOI":"10.1016\/j.envres.2023.116335","volume":"232","author":"N Gupta","year":"2023","unstructured":"Gupta N, Mohan CD, Shanmugam MK, Jung YY, Chinnathambi A, Alharbi SA, et al. CXCR4 expression is elevated in TNBC patient derived samples and Z-guggulsterone abrogates tumor progression by targeting CXCL12\/CXCR4 signaling axis in preclinical breast cancer model. Environ Res. 2023;232:116335.","journal-title":"Environ Res"},{"key":"2248_CR36","doi-asserted-by":"crossref","unstructured":"Song Y, Lu M, Feng L, Chen Q, Huang H, Lin Q. Identification of potential immunotherapy biomarkers for breast cancer by bioinformatics analysis. Biosci Rep. 2022;42(2):BSR20212035.","DOI":"10.1042\/BSR20212035"},{"key":"2248_CR37","unstructured":"Guozhi Y, Zhikui L, Yufeng W, Liankang S, Liang W, Bowen Y, et al. ZNF503 accelerates aggressiveness of hepatocellular carcinoma cells by down-regulation of GATA3 expression and regulated by microRNA-495. Am J translational Res. 2019;11(6):3426."},{"issue":"6","key":"2248_CR38","first-page":"3426","volume":"11","author":"G Yin","year":"2019","unstructured":"Yin G, Liu Z, Wang Y, Sun L, Wang L, Yao B, et al. ZNF503 accelerates aggressiveness of hepatocellular carcinoma cells by down-regulation of GATA3 expression and regulated by microRNA-495. Am J Transl Res. 2019;11(6):3426\u201337.","journal-title":"Am J Transl Res"},{"issue":"6","key":"2248_CR39","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41419-023-05888-9","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu X, Bai F, Wang Y, Wang C, Chan HL, Zheng C, et al. Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis. Cell Death Dis. 2023;14(6):370.","journal-title":"Cell Death Dis"},{"issue":"21","key":"2248_CR40","doi-asserted-by":"publisher","first-page":"34750","DOI":"10.18632\/oncotarget.16160","volume":"8","author":"HY Lin","year":"2017","unstructured":"Lin HY, Zeng D, Liang YK, Wei XL, Chen CF. GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignancies. Oncotarget. 2017;8(21):34750\u201361.","journal-title":"Oncotarget"},{"issue":"3","key":"2248_CR41","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1186\/bcr2327","volume":"11","author":"A Albergaria","year":"2009","unstructured":"Albergaria A, Paredes J, Sousa B, Milanezi F, Carneiro V, Bastos J, et al. Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours. Breast Cancer Res. 2009;11(3):R40.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"2248_CR42","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.humpath.2008.09.010","volume":"40","author":"V Ciocca","year":"2009","unstructured":"Ciocca V, Daskalakis C, Ciocca RM, Ruiz-Orrico A, Palazzo JP. The significance of GATA3 expression in breast cancer: a 10-year follow-up study. Hum Pathol. 2009;40(4):489\u201395.","journal-title":"Hum Pathol"},{"issue":"12","key":"2248_CR43","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.humpath.2010.06.010","volume":"41","author":"NK Yoon","year":"2010","unstructured":"Yoon NK, Maresh EL, Shen D, Elshimali Y, Apple S, Horvath S, et al. Higher levels of GATA3 predict better survival in women with breast cancer. Hum Pathol. 2010;41(12):1794\u2013801.","journal-title":"Hum Pathol"},{"key":"2248_CR44","doi-asserted-by":"crossref","unstructured":"Barrio IdMd, Wilkins GC, Meeson A, Ali S, Kirby JA. Breast cancer: an examination of the potential of ACKR3 to modify the response of CXCR4 to CXCL12. Int J Mol Sci. 2018;19(11):3592.","DOI":"10.3390\/ijms19113592"},{"key":"2248_CR45","doi-asserted-by":"crossref","unstructured":"Nguyen KTP, Druhan LJ, Avalos BR, Zhai L, Rauova L, Nesmelova IV, et al. CXCL12-CXCL4 heterodimerization prevents CXCL12-driven breast cancer cell migration. Cell Signal. 2020;66(C):109488.","DOI":"10.1016\/j.cellsig.2019.109488"},{"key":"2248_CR46","doi-asserted-by":"crossref","unstructured":"K AD WNM, Mohamad MOM, CM CE. Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation. Oncogene. 2018;37(32):4428\u201342.","DOI":"10.1038\/s41388-018-0263-7"},{"key":"2248_CR47","doi-asserted-by":"crossref","unstructured":"Jia-Chi M, Xiao-Wen S, He S, Quan C, Tian-Kang G, Yuan L, et al. Fibroblast-derived CXCL12\/SDF-1\u03b1 promotes CXCL6 secretion and co-operatively enhances metastatic potential through the PI3K\/Akt\/mTOR pathway in colon cancer. World J Gastroenterol. 2017;23(28):5167.","DOI":"10.3748\/wjg.v23.i28.5167"},{"issue":"1","key":"2248_CR48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/07357907.2017.1422512","volume":"36","author":"S Zhi-Yu","year":"2018","unstructured":"Zhi-Yu S, Feng W, Shu-Xiang C, Xian-Jun Q. Knockdown of CXCR4 inhibits CXCL12-induced angiogenesis in HUVECs through downregulation of the MAPK\/ERK and PI3K\/AKT and the Wnt\/\u03b2-catenin pathways. Cancer Invest. 2018;36(1):10\u20138.","journal-title":"Cancer Invest"},{"key":"2248_CR49","first-page":"8","volume":"42","author":"XSKWYWWW Q","year":"2022","unstructured":"Q XSKWYWWW. [MiR-372-5p regulates PI3K\/AKT\/CXCL12 signaling pathway by targeting PTEN to promote colorectal cancer cell metastasis]. Nan fang yi ke da xue xue bao = J South Med Univ. 2022;42:8.","journal-title":"Nan fang yi ke da xue xue bao = J South Med Univ"},{"issue":"1","key":"2248_CR50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12964-019-0432-5","volume":"17","author":"J Ma","year":"2019","unstructured":"Ma J, Sun X, Wang Y, Chen B, Qian L, Wang Y. Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k\/Akt signaling. Cell Commun Signal. 2019;17(1):119.","journal-title":"Cell Commun Signal"},{"issue":"4","key":"2248_CR51","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1158\/0008-5472.CAN-18-0620","volume":"79","author":"F Yang","year":"2019","unstructured":"Yang F, Takagaki Y, Yoshitomi Y, Ikeda T, Li J, Kitada M, et al. Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial-Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12\/CXCR4\/mTOR Axis. Cancer Res. 2019;79(4):735\u201346.","journal-title":"Cancer Res"},{"issue":"7","key":"2248_CR52","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/sj.bjc.6601661","volume":"90","author":"H Denys","year":"2004","unstructured":"Denys H, De Wever O, Nusgens B, Kong Y, Sciot R, Le AT, et al. Invasion and MMP expression profile in desmoid tumours. Br J Cancer. 2004;90(7):1443\u20139.","journal-title":"Br J Cancer"},{"issue":"1","key":"2248_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","volume":"25","author":"EI Deryugina","year":"2006","unstructured":"Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006;25(1):9\u201334.","journal-title":"Cancer Metastasis Rev"},{"key":"2248_CR54","doi-asserted-by":"crossref","unstructured":"Kwon MR, Park JS, Ko EJ, Park J, Ju EJ, Shin SH, et al. Ibulocydine inhibits migration and invasion of TNBC cells via MMP-9 regulation. Int J Mol Sci. 2024;25(11):6123.","DOI":"10.3390\/ijms25116123"},{"issue":"1","key":"2248_CR55","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12032-012-0335-4","volume":"30","author":"S Zhao","year":"2013","unstructured":"Zhao S, Ma W, Zhang M, Tang D, Shi Q, Xu S, et al. High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients. Med Oncol. 2013;30(1):335.","journal-title":"Med Oncol"},{"key":"2248_CR56","first-page":"187","volume":"14","author":"D Hammash","year":"2022","unstructured":"Hammash D, Mahfood M, Khoder G, Ahmed M, Tlili A, Hamoudi R, et al. miR-623 Targets Metalloproteinase-1 and Attenuates Extravasation of Brain Metastatic Triple-Negative Breast Cancer Cells. Breast Cancer (Dove Med Press). 2022;14:187\u201398.","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"1","key":"2248_CR57","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1080\/01635581.2021.1882511","volume":"74","author":"D Bizinelli","year":"2022","unstructured":"Bizinelli D, Flores Navarro F, Lima Costa Faldoni F. Maca Root (Lepidium meyenii) Extract Increases the Expression of MMP-1 and Stimulates Migration of Triple-Negative Breast Cancer Cells. Nutr Cancer. 2022;74(1):346\u201356.","journal-title":"Nutr Cancer"},{"key":"2248_CR58","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.canlet.2019.03.014","volume":"452","author":"JP Lim","year":"2019","unstructured":"Lim JP, Nair S, Shyamasundar S, Chua PJ, Muniasamy U, Matsumoto K, et al. Silencing Y-box binding protein-1 inhibits triple-negative breast cancer cell invasiveness via regulation of MMP1 and beta-catenin expression. Cancer Lett. 2019;452:119\u201331.","journal-title":"Cancer Lett"},{"key":"2248_CR59","doi-asserted-by":"crossref","unstructured":"Yihui Z, Zhonghua T, Ying C, Shuchen L, Mingyu Z, Wei J, et al. Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT. Breast Cancer Res Treat. 2022;193(1):65\u201381.","DOI":"10.1007\/s10549-022-06514-6"},{"issue":"1","key":"2248_CR60","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jss.2007.05.032","volume":"146","author":"S Cheng","year":"2008","unstructured":"Cheng S, Tada M, Hida Y, Asano T, Kuramae T, Takemoto N, et al. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma. J Surg Res. 2008;146(1):104\u20139.","journal-title":"J Surg Res"},{"issue":"1","key":"2248_CR61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/83158","volume":"2","author":"J Das","year":"2001","unstructured":"Das J, Chen CH, Yang L, Cohn L, Ray P, Ray A. A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol. 2001;2(1):45\u201350.","journal-title":"Nat Immunol"},{"key":"2248_CR62","doi-asserted-by":"publisher","first-page":"855645","DOI":"10.3389\/fimmu.2022.855645","volume":"13","author":"M Xu","year":"2022","unstructured":"Xu M, Kong Y, Chen N, Peng W, Zi R, Jiang M, et al. Identification of Immune-Related Gene Signature and Prediction of CeRNA Network in Active Ulcerative Colitis. Front Immunol. 2022;13:855645.","journal-title":"Front Immunol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02248-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02248-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02248-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:02:47Z","timestamp":1777532567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02248-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,22]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2248"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02248-1","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,22]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were conducted with approval from the Experimental Animal Ethics Committee of Zhengzhou University (2023-yyy-035) and performed in strict accordance with established Guidelines for the Diagnosis and Treatment of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors reviewed and accepted the contents of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}